Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.

By C. Dykewicz. Clinical Infectious Diseases, 2001

614 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/045b3bf22ada6e9ecd911036b279894007a393d5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Parasitology

Citations in the corpus

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, methodology): “An adapted version of the ‘Infectious Diseases Society of America-United States Public Health Service Grading System’ was used (Table 1 [9]) to define the level of evidence and strength of each recommendation proposed by the group.”
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012, background): “By permission of the Infectious Diseases Society of America [86].”
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “Wong SL, Mangu PB, Choti MA et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.”
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “Al-Hawary MM, Francis IR, Chari ST et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association.”
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease (2019, methodology): “An adapted version of the ‘Infectious Diseases Society of America-United States Public Health Service Grading System’ [2] was used (see Table 1) to define the level of evidence (LoE) and grade of recommendation (GoR) for each of the recommendations proposed by the group.”
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2019, methodology): “Wells SA, Asa SL, Dralle H et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.”
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “Lyman GH, Temin S, Edge SB et al.; American Society of Clinical Oncology Clinical Practice.”
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017, neutral): “World Cancer Research Fund/American Institute for Cancer Research.”
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “Preliminary results were presented at the American Society of Clinical Oncology meeting in 2013, and demonstrated that PFS analysis favours radiotherapy; however, follow-up is too early for firm conclusions and survival results are not yet mature [47].”
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, background): “Travis WD, Brambilla E, Noguchi M et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/ European Respiratory Society classification.”